⌘K
Loading ticker…
As of 2026-08-24, Edwards Lifesciences Corp (EW) has a 3-month relative strength percentile of 59 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 51. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 2.3%, relative volume 0.75×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Diluted EPS, last 8 quarters. Positive EPS uses YoY change.
EW appears in 1 ETF as of Jun 2026: WBIL at 2.04% weight, $621K notional.
Held by 101 ETFs · $274M across latest filings · largest weight 2.98% (GDOC).
Top 1 by value, from SEC N-PORT-P filings dated Jun 2026.
| ETF | Weight | Value | Δ |
|---|---|---|---|
| WBIL | 2.04% | $621K | new |
As filed in N-PORT — quarterly holdings with up to ~60-day publication lag. Not live positioning.
Attention is elevated versus its own recent norm without the relative strength to match — the loud-but-lagging pattern. Worth a skeptical eye; not a short signal.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
Daily range, ATR, beta, and the math for a 1-ADR stop.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | EW Jan avg: -0.25% median: 0.33% win: 50% σ: 3.72% n: 4 2022-04-12 → 2026-07-31 | EW Feb avg: 4.54% median: 5.58% win: 75% σ: 4.02% n: 4 2022-04-12 → 2026-07-31 | EW Mar avg: 2.31% median: 2.02% win: 75% σ: 8.19% n: 4 2022-04-12 → 2026-07-31 | EW Apr avg: -1.91% median: 4.15% win: 60% σ: 9.42% n: 5 2022-04-12 → 2026-07-31 | EW May avg: 0.17% median: 2.62% win: 60% σ: 4.25% n: 5 2022-04-12 → 2026-07-31 | EW Jun avg: 3.44% median: 4.61% win: 60% σ: 6.68% n: 5 2022-04-12 → 2026-07-31 | EW Jul avg: -8.49% median: -4.85% win: 40% σ: 14.79% n: 5 2022-04-12 → 2026-07-31 | EW Aug avg: -0.92% median: -2.13% win: 50% σ: 9.62% n: 4 2022-04-12 → 2026-07-31 (current) | EW Sep avg: -6.94% median: -6.98% win: 0% σ: 2.31% n: 4 2022-04-12 → 2026-07-31 | EW Oct avg: -3.20% median: -3.24% win: 50% σ: 8.45% n: 4 2022-04-12 → 2026-07-31 | EW Nov avg: 6.13% median: 6.37% win: 100% σ: 0.69% n: 4 2022-04-12 → 2026-07-31 | EW Dec avg: 2.83% median: 1.06% win: 50% σ: 7.20% n: 4 2022-04-12 → 2026-07-31 |